Artiva Biotherapeutics Inc. (ARTV)
NASDAQ · Healthcare
Artiva Biotherapeutics Inc. Operating Income 2023–2025
Artiva Biotherapeutics Inc. annual/quarterly operating income history and growth rate from 2023 to 2024. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Artiva Biotherapeutics Inc. operating income for the quarter ending March 31, 2024 was -14.5 M.
- Artiva Biotherapeutics Inc. annual operating income for 2025 was -89.8 M, a 33.48% increase from 2024.
- Artiva Biotherapeutics Inc. annual operating income for 2024 was -67.3 M, a 119.37% increase from 2023.
- Artiva Biotherapeutics Inc. annual operating income for 2023 was -30.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Artiva Biotherapeutics Inc. Operating Income — FAQ
Artiva Biotherapeutics Inc. (ARTV) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Artiva Biotherapeutics Inc.'s operating income?
Artiva Biotherapeutics Inc. (ARTV) reported operating income of -$90M for fiscal 2025.
Where can I see ARTV's operating income history?
The chart and table above show Artiva Biotherapeutics Inc.'s operating income by year and by quarter, including the growth rate.